Revvity Gene Delivery GMBH
Gräfelfing, BY
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- sirion-biotech.com
- Founded
- 2007
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | -$1 |
| FY2024 | $52,970 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Lentiboost formulated, gmpgrade | NIH Clinical Center | $21,000 | |
| Lentiboost formulated, GMP-grade | NIH Clinical Center | $21,000 | |
| Lentiboost formulated, GMP-grade | NIH Clinical Center | $10,970 | |
| Lentiboost formulated, GMP-grade 1 X 1 ML | NIH Clinical Center | $12,887 | |
| Lentiboost formulated, GMP-grade; reagent for patient treatment. | NIH Clinical Center | $10,250 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Vector Biomed Inc. | Gaithersburg, MD | 325414 Biological Product (except Diagnostic) Manufacturing |
| Vector Biolabs | Malvern, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| IDT Biologika GMBH | Dessau-Roßlau, SA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Gigamune, Inc. | San Francisco, CA | — |
| Research Vector | Philadelphia, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Sirion Biotech GMBH is a foreign-owned, for-profit organization that specializes in providing viral vector technologies and products to support gene therapy research and patient treatments. The company has been registered to receive awards from the U.S. federal government since January 7, 2019, with its current registration in SAM.gov set to expire on February 15, 2025. Sirion Biotech GMBH primarily supplies LENTIBOOST formulated, GMP-grade viral vector products to the federal government, specifically to the Department of Health and Human Services National Institutes of Health Clinical Center. These high-quality, specialized reagents are crucial for advancing gene therapy research and supporting patient treatments in clinical settings.
The company has consistently secured prime federal contract awards from the NIH Clinical Center, with no subcontractors or set-aside designations mentioned in the available data. These awards have been in the form of firm-fixed price purchase orders, ranging in value from approximately $10,000 to $21,000. The goods provided by Sirion Biotech GMBH include LENTIBOOST formulated, GMP-grade lentiviral products and other viral vector reagents. These products are typically delivered from the company's facilities in Germany to meet specified completion dates, which have ranged from about one month to six months after the award date. The consistency in contract awards from 2021 to 2024 suggests an ongoing relationship between Sirion Biotech GMBH and the NIH Clinical Center, highlighting the company's important role in supporting the NIH's intramural research program and its efforts to advance treatments for complex medical conditions through gene therapy.
Quick answers
Is Revvity Gene Delivery GMBH registered in SAM.gov?
Yes. Revvity Gene Delivery GMBH's SAM.gov registration is active through June 4, 2027.
What is Revvity Gene Delivery GMBH's CAGE code?
Revvity Gene Delivery GMBH's CAGE code is DQ0D0, and its Unique Entity ID (UEI) is MSN6VLEJCHC5.
How much has Revvity Gene Delivery GMBH received in federal contracts?
Federal contracts obligated $52,970 to Revvity Gene Delivery GMBH in fiscal years 2023 through 2027.
What is Revvity Gene Delivery GMBH's most recent federal award?
Revvity Gene Delivery GMBH's most recent federal contract award is Lentiboost formulated, gmpgrade (75N90024P00380), from NIH Clinical Center, on May 7, 2024.
On GovTribe
See Revvity Gene Delivery GMBH's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors